HYPER TET 16.5 %
HUMAN IMMUNOGLOBULINS (TETANUS IMMUNOGLOBULIN (HUMAN)) : 16.5 % · DIN 00083194 · CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
Health Canada status: CANCELLED POST MARKET
What is HYPER TET?
HYPER TET 16.5 % contains HUMAN IMMUNOGLOBULINS (TETANUS IMMUNOGLOBULIN (HUMAN)) : 16.5 %. It is listed in the Health Canada Drug Product Database under DIN 00083194, held by CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD., supplied as LIQUID for INTRAMUSCULAR administration. Health Canada currently lists it as cancelled post market, status dated 25-Sep-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00083194 |
|---|---|
| Brand name | HYPER TET |
| Generic / active ingredient | HUMAN IMMUNOGLOBULINS (TETANUS IMMUNOGLOBULIN (HUMAN)) : 16.5 % |
| Manufacturer | CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD. |
| Strength | 16.5 % |
| Dosage form | LIQUID |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J06BB02 TETANUS IMMUNOGLOBULIN |
| AHFS class | 80:04.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 25-Sep-1998 |
| Original market date | 1959-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code J06BB02 TETANUS IMMUNOGLOBULIN. 1 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HYPERTET | 250 UNIT | SOLUTION | GRIFOLS THERAPEUTICS LLC | MARKETED | DIN 02520087 |
| HYPERTET S/D | 250 UNIT | SOLUTION | GRIFOLS THERAPEUTICS LLC | CANCELLED POST MARKET | DIN 02230697 |
| HYPERTET S/D | 250 UNIT | SOLUTION | GRIFOLS THERAPEUTICS LLC | CANCELLED PRE MARKET | DIN 02379619 |
Who else supplies TETANUS IMMUNOGLOBULIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TETANUS IMMUNOGLOBULIN appears in 5 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.